The Role of the Emergency Room Physician in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, lifelong and debilitating autoimmune disease of the central nervous system (CNS), characterized by inflammation in the optic nerve and spinal cord. At this time there are no approved drugs to treat NMOSD. This program will focus on recognizing the symptoms and signs of NMOSD, reviewing best practices for early diagnosis of the disease, and discussing the novel mechanisms of action of emerging treatments for NMOSD and clinical trial data on their safety and efficacy profiles.
Release Date: June 30, 2020
Expiration Date: June 30, 2021